BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25944898)

  • 1. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
    Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
    J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
    Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
    Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxO6 in glucose metabolism (FoxO6).
    Kim DH; Zhang T; Lee S; Dong HH
    J Diabetes; 2013 Sep; 5(3):233-40. PubMed ID: 23324123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.
    Kim DH; Lee S; Noh SG; Lee J; Chung HY
    Aging (Albany NY); 2024 Mar; 16(5):4095-4115. PubMed ID: 38441531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
    Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
    J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
    Xiong X; Tao R; DePinho RA; Dong XC
    PLoS One; 2013; 8(8):e74340. PubMed ID: 24015318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
    Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
    PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
    Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
    Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats.
    Chang WC; Wu JS; Chen CW; Kuo PL; Chien HM; Wang YT; Shen SC
    Nutrients; 2015 Dec; 7(12):9946-59. PubMed ID: 26633482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO integration of insulin signaling with glucose and lipid metabolism.
    Lee S; Dong HH
    J Endocrinol; 2017 May; 233(2):R67-R79. PubMed ID: 28213398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
    Kim DH; Zhang T; Lee S; Calabuig-Navarro V; Yamauchi J; Piccirillo A; Fan Y; Uppala R; Goetzman E; Dong HH
    Endocrinology; 2014 Apr; 155(4):1255-67. PubMed ID: 24437489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance.
    Nara N; Nakayama Y; Okamoto S; Tamura H; Kiyono M; Muraoka M; Tanaka K; Taya C; Shitara H; Ishii R; Yonekawa H; Minokoshi Y; Hara T
    J Biol Chem; 2007 Oct; 282(42):30794-803. PubMed ID: 17724031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP
    Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.
    Vatner DF; Weismann D; Beddow SA; Kumashiro N; Erion DM; Liao XH; Grover GJ; Webb P; Phillips KJ; Weiss RE; Bogan JS; Baxter J; Shulman GI; Samuel VT
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E89-100. PubMed ID: 23651850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
    Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK
    Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
    Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
    Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
    Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
    Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
    Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.